Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

K-111

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
The relationship between adipocytes and infiltrated macrophages in fat tissue is important for the pathogenesis of insulin… Expand
Is this relevant?
Review
2007
Review
2007
Kozva Co Ltd, under license from Roche Holding AG, is developing K-111, an orally available peroxisome proliferator-activated… Expand
Is this relevant?
Review
2006
Review
2006
INTRODUCTION Prevalence of the metabolic syndrome has increased dramatically in recent years. Optimal patient care demands a… Expand
  • table 1
  • table 2
  • figure 1
Is this relevant?
2004
2004
K-111 has been characterized as a potent peroxisome proliferator-activated receptor (PPAR)alpha activator. Antidiabetic potency… Expand
Is this relevant?
2003
2003
K-111, formerly BM 17.0744, (2,2-dichloro-12-(4-chlorophenyl)-dodecanoic acid) is a new insulin-sensitizer with peroxisome… Expand
Is this relevant?
2002
2002
This study was undertaken to investigate the hypocholesterolemic activity ofBifidobacteria (B. breve K-110,B. breve K-111, andB… Expand
Is this relevant?
2001
2001
Panax ginseng is widely used as a Chinese medicine, but it takes a long time to reach harvest and to establish its qualified… Expand
Is this relevant?
1999
1999
The protective effect of Bifidobacterium breve K-110, K-111 and B. infantis K-525 on carbon tetrachloride induced hepatotoxicity… Expand
Is this relevant?
1999
1999
Antidiarrheal, anticostive and antimutagenic effects of Bifidobacterium breve K-110, K-111 and B. infantis K-525 isolated from… Expand
Is this relevant?